CCR8 antagonist 2,99.71%
产品编号:Bellancom-144200| CAS NO:2756350-98-6| 分子式:C23H30ClN3O3S| 分子量:464.02
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
CCR8 antagonist 2
产品介绍 | CCR8 antagonist 2 是一种有效的 CCR8 拮抗剂。CCR8 (C-C Motif 趋化因子受体 8) 主要在 Treg 细胞和 Th2 细胞上表达,但不在 Th1 细胞上表达。CCR8 antagonist 2 抑制 CCR8 活性,可用于研究由 CCR8 介导的疾病,如癌症和/或神经性疼痛 (摘自专利 WO2022000443A1,化合物 220)。 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
生物活性 | CCR8 antagonist 2 is a potent antagonist of CCR8. CCR8 (C-C Motif Chemokine Receptor 8) is predominantly expressed on Treg cells and Th2 cells, but not on Th1 cells. CCR8 antagonist 2 inhibits CCR8 activity, which may be used in the research of diseases mediated by CCR8, such as cancer, and/or neuropathic pain (extracted from patent WO2022000443A1, compound 220). | ||||||||||||||||
体外研究 | |||||||||||||||||
体内研究 | |||||||||||||||||
体内研究 | |||||||||||||||||
性状 | Solid | ||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 4 mg/mL (8.62 mM; ultrasonic and warming and heat to 60°C) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) | ||||||||||||||||
参考文献 |